Search Results

Filter
  • 1-10 of  70 results for ""HIV Envelope Protein gp41""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents.

  • Authors : Mathys L; Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000, Leuven, Belgium. .; Balzarini J

Subjects: Virus Assembly* ; Virus Internalization* ; Virus Replication*

  • Source: Retrovirology [Retrovirology] 2014 Dec 11; Vol. 11, pp. 107. Date of Electronic Publication: 2014 Dec 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101216893 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-4690

Record details

×
Academic Journal

The M-T hook structure is critical for design of HIV-1 fusion inhibitors.

  • Authors : Chong H; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, 9 Dong Dan San Tiao, Beijing 100730, China.; Yao X

Subjects: Drug Design* ; HIV Envelope Protein gp41*/HIV Envelope Protein gp41*/HIV Envelope Protein gp41*/chemistry ; HIV Envelope Protein gp41*/HIV Envelope Protein gp41*/HIV Envelope Protein gp41*/metabolism

  • Source: The Journal of biological chemistry [J Biol Chem] 2012 Oct 05; Vol. 287 (41), pp. 34558-68. Date of Electronic Publication: 2012 Aug 09.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

×
Academic Journal

A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.

  • Authors : Chang CH; Immunomedics, Inc., Morris Plains, New Jersey, United States of America. ; Hinkula J

Subjects: Drug Design*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*pharmacology

  • Source: PloS one [PLoS One] 2012; Vol. 7 (7), pp. e41235. Date of Electronic Publication: 2012 Jul 23.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection.

  • Authors : Zhou C; Laboratory of Immunology, School of Life Sciences, Tsinghua University, Beijing 100084, China.; Lu L

Subjects: MAP Kinase Signaling System*; Antigens, Differentiation, B-Lymphocyte/Antigens, Differentiation, B-Lymphocyte/Antigens, Differentiation, B-Lymphocyte/*metabolism ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*metabolism

  • Source: The Journal of biological chemistry [J Biol Chem] 2011 Dec 30; Vol. 286 (52), pp. 44869-77. Date of Electronic Publication: 2011 Oct 28.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

×
Academic Journal

Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.

  • Authors : Izumi K; Institute for Virus Research, Kyoto University, 53 Kawaramachi, Shogoin, Kyoto 606-8507, Japan.; Kodama E

Subjects: Drug Resistance, Multiple/Drug Resistance, Multiple/Drug Resistance, Multiple/*drug effects ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*drug effects ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*pharmacology

  • Source: The Journal of biological chemistry [J Biol Chem] 2009 Feb 20; Vol. 284 (8), pp. 4914-20. Date of Electronic Publication: 2008 Dec 10.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

×
Academic Journal

Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication.

  • Authors : Steckbeck JD; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.; Craigo JK

Subjects: Conserved Sequence*; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*physiology ; HIV-1/HIV-1/HIV-1/*physiology

  • Source: The Journal of biological chemistry [J Biol Chem] 2011 Aug 05; Vol. 286 (31), pp. 27156-66. Date of Electronic Publication: 2011 Jun 09.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

×
Academic Journal

The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.

  • Authors : Chan WE; Institute of Biomedical Sciences, Academia Sinica, No. 128 Yen-Chiu-Yuan Road, Section 2, Nankang, Taipei 11529, Taiwan, ROC.; Chen SS

Subjects: Down-Regulation* ; Virus Replication*; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*genetics

  • Source: Journal of biomedical science [J Biomed Sci] 2007 Nov; Vol. 14 (6), pp. 717-29. Date of Electronic Publication: 2007 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1021-7770

Record details

×
Academic Journal

Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.

  • Authors : Chen SS; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China. ; Yang P

Subjects: Virus Replication*; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*metabolism ; HIV-1/HIV-1/HIV-1/*physiology

  • Source: Journal of virology [J Virol] 2009 Jan; Vol. 83 (2), pp. 870-83. Date of Electronic Publication: 2008 Nov 05.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.

  • Authors : Newman JT; Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, PA 15261, USA.; Sturgeon TJ

Subjects: Point Mutation* ; Virus Replication*; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*genetics

  • Source: Virology [Virology] 2007 Oct 10; Vol. 367 (1), pp. 102-16. Date of Electronic Publication: 2007 Jun 19.Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.

  • Authors : Olivieri K; Department of Microbiology and Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, VA 22908, USA.; Scoggins RM

Subjects: Cytopathogenic Effect, Viral*; HIV Envelope Protein gp120/HIV Envelope Protein gp120/HIV Envelope Protein gp120/*physiology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*physiology

  • Source: Virology [Virology] 2007 Feb 05; Vol. 358 (1), pp. 23-38. Date of Electronic Publication: 2006 Sep 26.Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  70 results for ""HIV Envelope Protein gp41""